Lantheus Holdings, Inc. Comparables

Find the most relevant public market comparables for Lantheus Holdings, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.

Company Overview

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company that develops, manufactures, and distributes diagnostic and therapeutic products for oncology, cardiology, and other therapeutic areas. They offer products assisting healthcare professionals in the diagnosis and treatment of various diseases. The company has a history spanning over 65 years and has made several acquisitions expanding their portfolio.

Business Model

Development, manufacturing, and distribution of radiopharmaceutical diagnostic and therapeutic products.

Target Customers

Hospitals, independent diagnostic testing facilities, government facilities, integrated delivery networks, radiopharmacies, and clinics.

Specific Focus

Precision diagnostic and therapeutic products, with a focus on oncology and cardiology.

Location

Bedford , Massachusetts

CEO

Brian Markison

Industry

Life sciences

Sub Sector

Radiopharmaceuticals

3yr Revenue Growth

282%

Public Market Comparables

Below are the key valuation metrics for companies similar to Lantheus Holdings, Inc. in the Pharmaceuticals sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.

Looking for a comprehensive compset for Lantheus Holdings, Inc.? Our platform provides detailed analysis of Lantheus Holdings, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Lantheus Holdings, Inc. compset by trying our platform today.

EV/Revenue Multiple

Min

0.0x

Median

0.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details

EV/EBITDA Multiple

Min

00.0x

Median

00.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details
Screenshot of CompSetFinder showing Lantheus Holdings, Inc. comps with valuation metrics like EV/Revenue, EV/EBITDA, and P/E

Unlock the Full Lantheus Holdings, Inc. Compset

As a leading player in the Life sciences industry within the Pharmaceuticals sector, Lantheus Holdings, Inc. operates in the specialized Radiopharmaceuticals sub-sector. Understanding how Lantheus Holdings, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.

Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Radiopharmaceuticals space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.

Get Your Custom Comparable Analysis

Need a more detailed analysis of Lantheus Holdings, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.

Try CompsetFinder Free